Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.1.1 Global Drivers for Pharmaceutical Demand 10
1.1.2 R&D Pipeline in the Pharmaceutical Industry 10
1.2 Industry Trends 14
2 Report Outline 15
2.1 Report Scope 15
2.2 Report Summary 15
2.3 Research Methodology 16
2.4 Report Assumptions 16
3 Market Snapshot 18
3.1 Market Definition - Infoholic Research 18
3.2 Causes of Thrombosis 18
3.3 Risk Factors for Thrombosis 18
3.4 Symptoms of Thrombosis 19
3.5 Diagnosis of Thrombosis 19
3.6 Segmented Addressable Market 19
3.7 Trends in the Thrombosis Drugs Market 20
3.8 Related Markets 21
3.8.1 Over-the-Counter (OTC) Drugs 21
3.8.2 Cardiovascular Drugs 22
3.8.3 Respiratory Drugs 23
4 Market Outlook 24
4.1 Market Segmentation 24
4.2 PEST Analysis 24
4.3 Porter 5(Five) Forces 25
5 Market Characteristics 27
5.1 DRO Analysis - Market Dynamics 27
5.1.1 Drivers 27
5.1.1.1 Increasing burden of cardiovascular disease and trauma cases 27
5.1.1.2 Upsurge in the geriatric and obese population 28
5.1.2 Opportunities 28
5.1.2.1 Increase in health care spending and demand for better treatment in emerging economies 28
5.1.2.2 Increasing new product launch and R&D activities 29
5.1.3 Restraints 29
5.1.3.1 Side effects associated with thrombosis drugs 29
5.1.3.2 Lack of awareness about thromboembolism conditions 29
5.2 DRO - Impact Analysis 30
5.3 Key Stakeholders 31
6 Drug Class: Market Size and Analysis 33
6.1 Overview 33
6.2 Factor Xa Inhibitors 34
6.3 Low Molecular Weight Heparin 35
6.4 P2Y12 Platelet Inhibitors 36
7 Indication: Market Size and Analysis 38
7.1 Overview 38
7.2 Deep Vein Thrombosis 38
7.3 Pulmonary Embolism 39
7.4 Atrial Fibrillation 39
8 Regions: Market Size and Analysis 40
8.1 Overview 40
8.2 North America 41
8.3 Europe 43
8.4 Asia Pacific 44
8.5 Rest of the World 45
9 Competitive Landscape 47
9.1 Overview 47
10 Vendors Profile 49
10.1 Aspen Pharmacare Holdings Limited 49
10.1.1 Overview 49
10.1.2 Business Units 50
10.1.3 Geographic Presence 51
10.1.4 Business Focus 52
10.1.5 SWOT Analysis 52
10.1.6 Business Strategies 53
10.2 Johnson & Johnson 53
10.2.1 Overview 53
10.2.2 Business Units 57
10.2.3 Geographic Presence 58
10.2.4 Business Focus 59
10.2.5 SWOT Analysis 60
10.2.6 Business Strategies 60
10.3 Sanofi S.A. 61
10.3.1 Overview 61
10.3.2 Business Units 64
10.3.3 Geographic Presence 65
10.3.4 Business Focus 66
10.3.5 SWOT Analysis 66
10.3.6 Business Strategies 66
10.4 Boehringer Ingelheim GmbH 67
10.4.1 Overview 67
10.4.2 Business Units 69
10.4.3 Geographic Presence 70
10.4.4 Business Focus 71
10.4.5 SWOT Analysis 71
10.4.6 Business Strategies 72
10.5 Bayer AG 72
10.5.1 Overview 72
10.5.2 Business Units 75
10.5.3 Geographic Presence 76
10.5.4 Business Focus 77
10.5.5 SWOT Analysis 77
10.5.6 Business Strategies 78
10.6 Bristol-Myers Squibb 78
10.6.1 Overview 78
10.6.2 Business Units 82
10.6.3 Geographic Presence 83
10.6.4 Business Focus 83
10.6.5 SWOT Analysis 83
10.6.6 Business Strategies 84
11 Companies to Watch For 85
11.1 AstraZeneca PLC 85
11.1.1 Overview 85
11.2 Pfizer Inc. 87
11.2.1 Overview 87
11.3 Baxter International Inc. 89
11.3.1 Overview 89
11.4 Daiichi Sankyo 91
11.4.1 Overview 91
Annexure 93
Abbreviations 93

?